FDA recalls another blood pressure medication for possible cancer risk

Desiree Burns
January 5, 2019

The recall is voluntary and affects 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP.

The health regulator said it will continue to investigate and test all angiotensin II receptor blockers for the presence of NDEA and another probable carcinogen N-nitrosodimethylamine. The chemical is typically found in very small amounts in some foods, drinking water, air pollution and certain industrial processes. The company, torrent Pharmaceuticals Limited, recently announced this particular recall which is for the two loots of the Losartan potassium tablets, on the website of the FDA, which is the Food and Drug Administration in the United States.

An important recall concerning blood pressure medication was released by the FDA on Wednesday. However, patients should consult with their pharmacist or physician who can advise them on alternative treatments.

Million Unencrypted Passport Numbers Accessed in Starwood Breach
There is no evidence at this time that the hacker was able to access the master decryption key for the encrypted numbers. The company also said it believes that approximately 8.6 million encrypted payment cards were involved in the attack.

It is also suggested that consumers contact their healthcare provider if they experience any issues with the medication.

To date, Aurobindo Pharma USA, Inc. hasn't received any reports of adverse events related to the recall. To 5 p.m. EST or by email at rxrecalls@inmar.com. Some tablets may contain a possible cancer-causing substance. A doctor (R) examines a patient on September 25, 2012 in Godewaersvelde, northern France, during a medical check-up.

Other reports by

Discuss This Article